Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Viracept 625 Mg Tabs 120 By Viiv Healthcare.

Image 0 of Viracept 625 Mg Tabs 120 By Viiv Healthcare. Image 1 of Viracept 625 Mg Tabs 120 By Viiv Healthcare.

Viracept 625 Mg Tabs 120 By Viiv Healthcare.

Call for Price

Viracept 625 Mg Tabs 120 By Viiv Healthcare. This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD3574647/RXB10061428/RXA322536
Size : 120
Selling UoM : EA
NDC: 63010-0027-70
UPC Barcode : 363010027703
Supplier: 0050002206 VIIV HEALTHCARE
Supplier Material : 9203
Generic Code : 052160 NELFINAVIR MESYLATE ORAL TABLET 625 MG
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : BRX Branded RX

Have a question?

  Call for Price

Product Description.:

V, 625
tablet , white , oval oblong

VIRACEPT? (nelfinavir mesylate) is an inhibitor of the human immunodeficiency virus (HIV) protease. VIRACEPT Tablets are available for oral administration as a light blue, capsule-shaped tablet with a clear film coating in 250 mg strength (as nelfinavir free base) and as a white oval tablet with a clear film coating in 625 mg strength (as nelfinavir free base). Each tablet contains the following common inactive ingredients: calcium silicate, crospovidone, magnesium stearate, hypromellose, and triacetin. In addition, the 250 mg tablet contains FD&C blue #2 powder and the 625 mg tablet contains colloidal silicon dioxide. VIRACEPT Oral Powder is available for oral administration in a 50 mg/g strength (as nelfinavir free base) in bottles. The oral powder also contains the following inactive ingredients: microcrystalline cellulose, maltodextrin, dibasic potassium phosphate, crospovidone, hypromellose, aspartame, sucrose palmitate, and natural and artificial flavor.

INDICATIONS

VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV infection.

SIDE EFFECTS

The safety of VIRACEPT was studied in over 5000 patients who received drug either alone or in combination with nucleoside analogues. The majority of adverse events were of mild intensity. The most frequently reported adverse event among patients receiving VIRACEPT was diarrhea, which was generally of mild to moderate intensity.